Products
Inosipranol 500 mg and 1000 mg powder for oral solution
Generic name: | Inosine pranobex |
АТС code: | J05AX05 |
Composition: | Each sachet inosipranol contains 500 mg or 1000 mg inosine pranobex, respectively. |
Group: | Antivirals for systemic use |
Subgroup: Direct acting antivirals, Other antivirals
Medical product subject to medical prescription
Route (s) of administration: Oral use
Nature and contents of container:
Inosipranol 500 mg powder for oral solution: paper/polyethylene/aluminium sachets packed in cartons containing 20, 30 and 50 sachets, together with a package leaflet.
Inosipranol 1000 mg powder for oral solution: paper/polyethylene/aluminium sachets packed in cartons containing 20 sachets, together with a package leaflet.
Description:
Inosipranol contains the active ingredient inosine pranobex, which is used to treat certain viral infections and to enhance the body's natural immunity and immune response to viral infections. The drug mainly affects the components of cellular immunity. It also has an anti-viral effect.
Indications:
Inosipranol is used to stimulate your immune system to overcome viral infections, such as:
- influenza/viral respiratory infections;
- repeated/recurrent genital herpes;
- repeated/recurrent herpes simplex of the lips;
- herpes zoster (painful infection with vesicles along a nerve);
- varicalla (chicken pox);
- measles (smallpox - respiratory tract infection with fever and skin rash);
- parotitis/mumps (a viral infection that can lead to swelling and pain in the parotid salivary glands);
- viral hepatitis;
- genital warts and other infections caused by the human papilloma virus;
- other viral infections, such as infectious mononucleosis (infection caused by Epstein-Bar virus), infection caused by cytomegalovirus;
- subacute sclerosing pancephalitis (a neurological disease of children and young people which affects the central nervous system).
Products manufactured under contract
Generic name | Pharmaceutical form | АТС code |
---|---|---|
Acetylsalicylic acid | Tablets 500 mg | C01DA05 |
Azithromycin | Hard capsules 250 mg | J01FA10 |
Azithromycin | Powder for oral suspension 100 mg/5 ml, 20 ml | J01FA10 |
Azithromycin | Powder for oral suspension 200 mg/5 ml, 20 ml | J01FA10 |
Bifonazole | Cream 1%, 15 g | D01AC10 |
Chloramphenicol | Hard capsules 250 mg | J01BA01 |
Chloramphenicol | Ointment 2 %, 20 g | D06AX02 |
Cinnarizine | Tablets 25 mg | N07CA02 |
Clindamycin | Hard capsules 150 mg | J01FF01 |
Clobetasol propionate | Cream 0,5 mg/g, 15 g | D07AD01 |
Clobetasol propionate | Ointment 0,5 mg/g, 15 g | D07AD01 |
Dequalinium chloride; Ascorbic acid | Compressed lozenges | C01DA05 |
Dexamethasone, Tobramycin | Eye drops, suspension 3 mg/ml + 1 mg/ml, 5 ml | S01CA01 |
Dimenhydrinate | Tablets 50 mg | R06AA00 |
Doxycyclin | Hard capsules 100 mg | J01AA02 |
Fluconazole | Hard capsules 50 mg | J02AC01 |
Fluconazole | Hard capsules 100 mg | J02AC01 |
Fluocinolone acetonide | Ointment 0,25 mg/g, 15 g | D07AC04 |
Fluocinolone acetonide | Cream 0,25 mg/g, 15 g | D07AC04 |
Fluocinolone acetonide, Neomycin | Cream 0,25 mg/g + 5 mg/g, 15 g | D07CC02 |
Fluocinolone acetonide, Neomycin | Ointment 0,25 mg/g + 5 mg/g, 15 g | D07CC02 |
Gentamicin | Cream 1 mg/g, 15 g | D06AX07 |
Gentamicin | Ointment 1 mg/g, 15 g | D06AX07 |
Gentamicin, Hydrocortisone | Cream 1 mg/g + 10 mg/g, 15 g | D07CA01 |
Gentamicin, Hydrocortisone | Ointment 1 mg/g + 10 mg/g, 15 g | D07CA01 |
Hydrochlorothiazide | Tablets 25 mg | C03AA03 |
Hydrocortisone, Chloramphenicol | Eye drops, suspension 10 mg/ml + 2 mg/ml, 5 ml | S01CA03 |
Hydrocortisone, Neomycin | Cream 10 mg/g + 3,5 mg/g, 15 g | D07CA01 |
Hydrocortisone, Neomycin | Ointment 25 mg/g + 25 mg/g, 10 g | D07CA01 |
Indapamide hemihydrate | Film-coated tablets 2,5 mg | C03BA11 |
Isosorbide dinitrate | Tablets 10 mg | C01DA08 |
Isosorbide dinitrate | Prolonged-realese tablets 20 mg | C01DA08 |
Lincomycin | Hard capsules 500 mg | J01FF02 |
Lovastatin | Tablets 20 mg | C10AA02 |
Lovastatin | Tablets 40 mg | C10AA02 |
Magnesium DL-aspartate tetrahydrate, Potassium DL-aspartate hemihydrate | Film-coated tablets 175 mg + 166 mg | A12BA30 |
Metamizole sodium, Thiamine hydrochloride, Caffeine | Tablets 500 mg + 50 mg + 38,75 mg | N02BB52 |
Nystatin | Cream 100 000 IU/g, 15 g | D01AA01 |
Nystatin | Ointment 100 000 IU/g, 15 g | D01AA01 |
Nystatin | Tablets 500 000 IU | A07AA02 |
Oleandomycin, Dexamethasone, Indometacin | Oromucisal paste 50 mg/g + 10 mg/g + 50 mg/g, 5 ml | A01AD11 |
Papaverine hydrochloride | Tablets 50 mg | A03AD01 |
Pentaerithrityl tetranitrate | Tablets 10 mg | C01DA05 |
Piracetam | Film-coated tablets 800 mg | N06BX03 |
Piracetam | Hard Capsules 400 mg | N06BX03 |
Propranolol hydrochloride | Tablets 20 mg | C07AA05 |
Propranolol hydrochloride | Tablets 40 mg | C07AA05 |
Rifampicin | Hard capsules 300 mg | J04AB02 |
Tetracycline | Ointment 3 %, 20 g | D06AA04 |
Tetracycline | Hard capsules 250 mg | J01AA07 |
Tobramycin | Eye drops, solution 0,3 %, 5 ml | S01AA12 |
Triamterene, Hydrochlorothiazide | Tablets 25 mg + 12,5 mg | C03EA01 |
Troxerutin | Hard capsules 300 mg | C05CA04 |
New products
Aciclovir Vision 30 mg/g eye ointment
Subgroup: Antiinfectives, Antiviral products Medical product subject to medical prescription Route (s) of administration: Ocular use Nature and contents of container: The medicinal product is packe...
MorePrednisolon F 2 mg tablets
Subgroup: Glucocorticoids Medical product subject to medical prescription Route (s) of administration: Oral use Nature and contents of container: 10 (ten) tablets are packed in a PVC / PVdC / AL fo...
MoreInosipranol 500 mg and 1000 mg powder for oral solution
Subgroup: Direct acting antivirals, Other antivirals Medical product subject to medical prescription Route (s) of administration: Oral use Nature and contents of container: Inosipranol 500 m...
MoreClindavasin D 10 mg/ml cutaneous solution
Indications: Clindavasin D 10 mg/ml cutaneous solution is used to apply to the skin to treat acne vulgaris. Medical product subject to medical prescription Route (s) of administration: Clindavasin D...
More